Lista de obras - Antonio Salar - Dominio Público Uruguay

A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome

article

A higher JAK2 V617F-mutated clone is observed in platelets than in granulocytes from essential thrombocythemia patients, but not in patients with polycythemia vera and primary myelofibrosis

A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

artículo científico publicado en 2010

A new modified prophylactic scheme against liposomal cytarabine-induced arachnoiditis in adult patients with lymphoma.

artículo científico publicado en 2012

A phase II study to evaluate lenalidomide in combination with metronomic-dose cyclophosphamide in patients with heavily pretreated classical Hodgkin lymphoma

artículo científico publicado en 2015

A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia

artículo científico publicado en 2008

Absence of mutations of the histone methyltransferase gene EZH2 in splenic b-cell marginal zone lymphoma

article

Acute myeloid dendritic cell leukaemia with specific cutaneous involvement: a diagnostic challenge

artículo científico publicado en 2008

Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy: results from an observational study

artículo científico publicado en 2011

Anthracycline-induced cardiotoxicity in diffuse large B-cell lymphoma: NT-proBNP and cardiovascular score for risk stratification

artículo científico publicado en 2019

Anti-tumor activity of the combination of bendamustine with vorinostat in diffuse large B-cell lymphoma cells.

artículo científico publicado en 2015

Aplastic Anemia and Severe Myelosuppression with Boceprevir or Simeprevir-Containing Hepatitis C Virus Treatment.

artículo científico publicado en 2017

Attitudes of physicians toward assessing risk and using granulocyte colony-stimulating factor as primary prophylaxis in patients receiving chemotherapy associated with an intermediate risk of febrile neutropenia

artículo científico

Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens

artículo científico publicado en 2001

Bendamustine-containing immunochemotherapy is active in transformed follicular lymphoma with overexpression of p53.

artículo científico publicado en 2009

Blastic Plasmacytoid Dendritic Cell Neoplasm Associated with Dystrophic Xanthomatosis after Chemotherapy

artículo científico publicado en 2017

Central nervous system involvement from primary cutaneous large B-cell lymphoma of the leg.

artículo científico publicado en 2008

Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial

artículo científico publicado en 2016

Circulating cell-free DNA improves the molecular characterisation of Ph-negative myeloproliferative neoplasms

scientific article published on 18 September 2020

Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas

scientific article published on 05 April 2020

Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain

artículo científico publicado en 2011

Clinical practice guidelines for first-line/after-relapse treatment of patients with follicular lymphoma.

artículo científico publicado en 2011

Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era

artículo científico publicado en 2010

Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type

artículo científico publicado en 2009

Comparison of subcutaneous versus intravenous administration of rituximab as maintenance treatment for follicular lymphoma: results from a two-stage, phase IB study

artículo científico publicado en 2014

Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome

scientific article published on 05 February 2014

Cost-Effectiveness Analysis of Bendamustine Plus Rituximab as a First-Line Treatment for Patients with Follicular Lymphoma in Spain.

artículo científico publicado en 2016

Cutaneous lymphomas showing prominent granulomatous component: clinicopathological features in a series of 16 cases

artículo científico publicado en 2009

Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.

artículo científico publicado en 2010

Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma.

artículo científico publicado en 2014

Diarrheic syndrome as a clinical sign of intestinal infiltration in progressive B-cell chronic lymphocytic leukemia

artículo científico publicado en 2008

Differential Impact of Relative Dose-Intensity Reductions in Diffuse Large B-Cell Lymphoma Treated with R-CHOP21 or R-CHOP14.

artículo científico publicado en 2015

Diffuse large B-cell lymphoma associated with chronic inflammation in metallic implant.

artículo científico publicado en 2013

Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry

artículo científico publicado en 2013

Double diagnosis in cancer patients and cutaneous reaction related to gemcitabine: CASE 1. Synchronous mucosa-associated lymphoid tissue lymphoma and gastrointestinal stromal tumors of the stomach

artículo científico publicado en 2005

Engraftment syndrome and survival after respiratory failure post-bone marrow transplantation

scientific article published on 01 July 1998

Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab era

artículo científico publicado en 2019

First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosa-associated lymphoid tissue lymphoma (MALT2008-01): a multicentre, single-arm, phase 2 trial

artículo científico publicado en 2014

First-line treatment with rituximab-hyperCVAD alternating with rituximab-methotrexate-cytarabine and followed by consolidation with 90Y-ibritumomab-tiuxetan in patients with mantle cell lymphoma. Results of a multicenter, phase 2 pilot trial [...]

artículo científico publicado en 2013

Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03).

artículo científico publicado en 2011

Gastrointestinal involvement in mantle cell lymphoma: a prospective clinic, endoscopic, and pathologic study

artículo científico publicado en 2006

Granulomatous dermatitis with enlarged histiocytes: a characteristic pattern of granulocyte colony-stimulating factor. Report of two cases and review of the literature.

artículo científico publicado en 2006

Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO).

artículo científico publicado en 2016

Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics

artículo científico publicado en 2016

Hypopituitarism associated with mycotic aneurysm of the cavernous carotid artery in a renal transplant recipient

artículo científico publicado en 2006

Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry.

artículo científico publicado en 2009

Impact of prior rituximab on outcomes of autologous stem-cell transplantation in patients with relapsed or refractory aggressive B-cell lymphoma: a multicentre retrospective Spanish group of lymphoma/autologous bone marrow transplant study.

artículo científico publicado en 2013

Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice

artículo científico publicado en 2012

Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma.

artículo científico publicado en 2010

Incidence of chemotherapy-induced neutropenia and current practice of prophylaxis with granulocyte colony-stimulating factors in cancer patients in Spain: a prospective, observational study.

artículo científico publicado en 2013

Indolent course as presentation in t-prolymphocytic leukaemia

artículo científico publicado en 1999

Infliximab and adalimumab-induced thrombocytopenia in a woman with colonic Crohn's disease

artículo científico publicado en 2007

Influence of MBL-2 mutations in the infection risk of patients with follicular lymphoma treated with rituximab, fludarabine, and cyclophosphamide.

artículo científico publicado en 2009

Intermediate dose of nonpegylated liposomal doxorubicin combination (R-CMyOP) as first line chemotherapy for frail elderly patients with aggressive lymphoma

artículo científico publicado en 2010

Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma

artículo científico publicado en 2012

Langerhans' cell histiocytosis mimicking relapse in a patient with follicular lymphoma

artículo científico publicado en 2008

Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group.

artículo científico publicado en 2016

Lenalidomide-induced paronychia

artículo científico publicado en 2013

Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population

artículo científico publicado en 2019

Long-Term Follow-Up of a Phase II Trial of Six Cycles of Dose-Dense R-CHOP-14 for First-Line Treatment of Diffuse Large B-Cell Lymphoma in Young and Elderly Patients.

artículo científico publicado en 2016

Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma.

artículo científico publicado en 2017

Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trial

artículo científico publicado en 2017

MYD88 (L265P) mutation is an independent prognostic factor for outcome in patients with diffuse large B-cell lymphoma

artículo científico publicado en 2014

Metronomic chemotherapy for advanced and refractory cutaneous T-cell lymphoma treatment

artículo científico publicado en 2014

MicroRNAs 142-3p, miR-155 and miR-203 Are Deregulated in Gastric MALT Lymphomas Compared to Chronic Gastritis

artículo científico publicado en 2017

Modulation of JAK2 V617F allele burden dynamics by hydroxycarbamide in polycythaemia vera and essential thrombocythaemia patients

article

Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA ⬇️

scientific article published on 01 May 2022

Monoclonal cryoglobulinemia: the first manifestation of gastric marginal B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).

artículo científico publicado en 2006

NT-proBNP: a cardiac biomarker to assess prognosis in non-Hodgkin lymphoma

artículo científico publicado en 2011

New chromosomal alterations in a series of 23 splenic marginal zone lymphoma patients revealed by Spectral Karyotyping (SKY)

article by Cristina Baró et al published May 2008 in Leukemia Research

Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification

artículo científico publicado en 1998

Persistent monoclonality after histological remission in gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy and/or surgery: influence of t(11;18)(q21;q21)

artículo científico publicado en 2008

Persistent residual disease in t(11;18)(q21;q21) positive gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy or rituximab

scientific article published on 01 October 2005

Pneumonia caused by Micrococcus species in a neutropenic patient with acute leukemia

scientific article published on 01 July 1997

Postpolycythaemic myelofibrosis: frequency and risk factors for this complication in 116 patients.

artículo científico publicado en 2009

Posttransplant lymphoproliferative disease: treatment and outcome in renal transplant recipients

artículo científico publicado en 2003

Predictive value of interim ¹⁸F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment.

artículo científico publicado en 2013

Primary cutaneous diffuse large B-cell lymphoma, leg type and secondary cutaneous involvement by testicular B-cell lymphoma share identical clinicopathological and immunophenotypical features

artículo científico publicado en 2011

Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia

artículo científico publicado en 1999

Progressive painless swelling of glans penis: uncommon clinical manifestation of systemic non-Hodgkin's lymphoma

artículo científico publicado en 2008

Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease

artículo científico publicado en 2007

R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.

artículo científico publicado en 2008

Rapid infusion of rituximab with or without steroid-containing chemotherapy: 1-yr experience in a single institution

scientific article published on 19 July 2006

Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma.

artículo científico

Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08

artículo científico publicado en 2019

Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group

artículo científico publicado en 2017

Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases

artículo científico publicado en 2012

Simplification of risk stratification for splenic marginal zone lymphoma: a point-based score for practical use.

artículo científico publicado en 2013

Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria.

artículo científico publicado en 2007

Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series.

artículo científico publicado en 2012

Study of regulatory T-cells in patients with gastric malt lymphoma: influence on treatment response and outcome

artículo científico publicado en 2012

Successful dexrazoxane treatment of a potentially severe extravasation of concentrated doxorubicin

artículo científico publicado en 2010

The need for improved neutropenia risk assessment in DLBCL patients receiving R-CHOP-21: findings from clinical practice.

artículo científico publicado en 2012

Thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma concurrently diagnosed with a diffuse large B-cell lymphoma localized in the neck.

artículo científico publicado en 2007

Usefulness of second rituximab maintenance after relapse in patients with follicular and mantle cell lymphoma

artículo científico publicado en 2014

Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of β2 -microglobulin yields a more accurate GELTAMO-IPI.

artículo científico publicado en 2017

Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.

artículo científico publicado en 2013

[Prognostic impact of anthracyclines in the treatment of aggressive lymphoma in patients over 70 years]

artículo científico publicado en 2014

Lista de obras de Antonio Salar

A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome

A higher JAK2 V617F-mutated clone is observed in platelets than in granulocytes from essential thrombocythemia patients, but not in patients with polycythemia vera and primary myelofibrosis

A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

A new modified prophylactic scheme against liposomal cytarabine-induced arachnoiditis in adult patients with lymphoma.

A phase II study to evaluate lenalidomide in combination with metronomic-dose cyclophosphamide in patients with heavily pretreated classical Hodgkin lymphoma

A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia

Absence of mutations of the histone methyltransferase gene EZH2 in splenic b-cell marginal zone lymphoma

Acute myeloid dendritic cell leukaemia with specific cutaneous involvement: a diagnostic challenge

Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy: results from an observational study

Anthracycline-induced cardiotoxicity in diffuse large B-cell lymphoma: NT-proBNP and cardiovascular score for risk stratification

Anti-tumor activity of the combination of bendamustine with vorinostat in diffuse large B-cell lymphoma cells.

Aplastic Anemia and Severe Myelosuppression with Boceprevir or Simeprevir-Containing Hepatitis C Virus Treatment.

Attitudes of physicians toward assessing risk and using granulocyte colony-stimulating factor as primary prophylaxis in patients receiving chemotherapy associated with an intermediate risk of febrile neutropenia

Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens

Bendamustine-containing immunochemotherapy is active in transformed follicular lymphoma with overexpression of p53.

Blastic Plasmacytoid Dendritic Cell Neoplasm Associated with Dystrophic Xanthomatosis after Chemotherapy

Central nervous system involvement from primary cutaneous large B-cell lymphoma of the leg.

Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial

Circulating cell-free DNA improves the molecular characterisation of Ph-negative myeloproliferative neoplasms

Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas

Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain

Clinical practice guidelines for first-line/after-relapse treatment of patients with follicular lymphoma.

Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era

Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type

Comparison of subcutaneous versus intravenous administration of rituximab as maintenance treatment for follicular lymphoma: results from a two-stage, phase IB study

Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome

Cost-Effectiveness Analysis of Bendamustine Plus Rituximab as a First-Line Treatment for Patients with Follicular Lymphoma in Spain.

Cutaneous lymphomas showing prominent granulomatous component: clinicopathological features in a series of 16 cases

Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.

Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma.

Diarrheic syndrome as a clinical sign of intestinal infiltration in progressive B-cell chronic lymphocytic leukemia

Differential Impact of Relative Dose-Intensity Reductions in Diffuse Large B-Cell Lymphoma Treated with R-CHOP21 or R-CHOP14.

Diffuse large B-cell lymphoma associated with chronic inflammation in metallic implant.

Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry

Double diagnosis in cancer patients and cutaneous reaction related to gemcitabine: CASE 1. Synchronous mucosa-associated lymphoid tissue lymphoma and gastrointestinal stromal tumors of the stomach

Engraftment syndrome and survival after respiratory failure post-bone marrow transplantation

Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab era

First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosa-associated lymphoid tissue lymphoma (MALT2008-01): a multicentre, single-arm, phase 2 trial

First-line treatment with rituximab-hyperCVAD alternating with rituximab-methotrexate-cytarabine and followed by consolidation with 90Y-ibritumomab-tiuxetan in patients with mantle cell lymphoma. Results of a multicenter, phase 2 pilot trial [...]

Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03).

Gastrointestinal involvement in mantle cell lymphoma: a prospective clinic, endoscopic, and pathologic study

Granulomatous dermatitis with enlarged histiocytes: a characteristic pattern of granulocyte colony-stimulating factor. Report of two cases and review of the literature.

Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO).

Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics

Hypopituitarism associated with mycotic aneurysm of the cavernous carotid artery in a renal transplant recipient

Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry.

Impact of prior rituximab on outcomes of autologous stem-cell transplantation in patients with relapsed or refractory aggressive B-cell lymphoma: a multicentre retrospective Spanish group of lymphoma/autologous bone marrow transplant study.

Importance of granulocyte colony-stimulating factor prophylaxis in therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone given every 14 days for diffuse large B-cell lymphoma in routine clinical practice

Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma.

Incidence of chemotherapy-induced neutropenia and current practice of prophylaxis with granulocyte colony-stimulating factors in cancer patients in Spain: a prospective, observational study.

Indolent course as presentation in t-prolymphocytic leukaemia

Infliximab and adalimumab-induced thrombocytopenia in a woman with colonic Crohn's disease

Influence of MBL-2 mutations in the infection risk of patients with follicular lymphoma treated with rituximab, fludarabine, and cyclophosphamide.

Intermediate dose of nonpegylated liposomal doxorubicin combination (R-CMyOP) as first line chemotherapy for frail elderly patients with aggressive lymphoma

Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma

Langerhans' cell histiocytosis mimicking relapse in a patient with follicular lymphoma

Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group.

Lenalidomide-induced paronychia

Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population

Long-Term Follow-Up of a Phase II Trial of Six Cycles of Dose-Dense R-CHOP-14 for First-Line Treatment of Diffuse Large B-Cell Lymphoma in Young and Elderly Patients.

Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma.

Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trial

MYD88 (L265P) mutation is an independent prognostic factor for outcome in patients with diffuse large B-cell lymphoma

Metronomic chemotherapy for advanced and refractory cutaneous T-cell lymphoma treatment

MicroRNAs 142-3p, miR-155 and miR-203 Are Deregulated in Gastric MALT Lymphomas Compared to Chronic Gastritis

Modulation of JAK2 V617F allele burden dynamics by hydroxycarbamide in polycythaemia vera and essential thrombocythaemia patients

Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA ⬇️

Monoclonal cryoglobulinemia: the first manifestation of gastric marginal B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).

NT-proBNP: a cardiac biomarker to assess prognosis in non-Hodgkin lymphoma

New chromosomal alterations in a series of 23 splenic marginal zone lymphoma patients revealed by Spectral Karyotyping (SKY)

Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification

Persistent monoclonality after histological remission in gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy and/or surgery: influence of t(11;18)(q21;q21)

Persistent residual disease in t(11;18)(q21;q21) positive gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy or rituximab

Pneumonia caused by Micrococcus species in a neutropenic patient with acute leukemia

Postpolycythaemic myelofibrosis: frequency and risk factors for this complication in 116 patients.

Posttransplant lymphoproliferative disease: treatment and outcome in renal transplant recipients

Predictive value of interim ¹⁸F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment.

Primary cutaneous diffuse large B-cell lymphoma, leg type and secondary cutaneous involvement by testicular B-cell lymphoma share identical clinicopathological and immunophenotypical features

Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia